CA41892-2A - 0x0000000000006162
Healthy Males & Females
Alloy
* El estipendio puede pagar hasta el monto reflejado.
Start Date:
May 13, 2024 - 2:15pm
End Date:
May 21, 2024 - 9:00am
Study Details
Study Number: CA41892
Group Number: 2A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat multiple sclerosis.
Route of Administration: Oral
Blood Draws: 19
Study Schedule
Schedule Type: Short stays with returns
Study Length: 4 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 5/7/2024 |
| Friday | 5/10/2024 |
| Saturday | 5/11/2024 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 5/7/2024 |
| Friday | 5/10/2024 |
| Saturday | 5/11/2024 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Monday | 5/13/2024 2:15:00 PM | Friday | 5/17/2024 11:15:00 AM | 1 | Lincoln |
| Return | Tuesday | 5/21/2024 7:30:00 AM | Tuesday | 5/21/2024 9:00:00 AM | 1 | Lincoln |
